The group of researchers
from Brown University
Medical School analyzed, in
the frontal part of the
brain, one of the major
area affected by
Alzheimer's, insulin and
insulin receptor
function.
The team discovered that
the levels of insulin
receptors and the brain's
ability to respond to
insulin decreased as the
severity of Alzheimer's
increased.
According to the
experts, insulin receptors
were nearly 80 percent
lower than in a normal
brain in the most advanced
stage of Alzheimer's.
Two abnormal situations
related to insulin in
Alzheimer's were also found
by researchers. The first
abnormal situation was that
as the disease progressed,
levels of insulin dropped.
In relation to the second
one, experts explained that
insulin and its related
protein, insulin-related
growth factor-I, lose the
ability to bind to cell
receptors, which creates a
resistance to the insulin
growth factors, causing the
cells to malfunction and
die.
For the neuropathologist
at Rhode Island Hospital
and professor of pathology
at Brown University Medical
School, Suzanne M. de la
Monte, this means that they
are able to show that
insulin impairment happens
early in the disease, as
well as they are able to
show it is linked to major
neurotransmitters
responsible for
cognition.
“We're able to show it's
linked to poor energy
metabolism, and it's linked
to abnormalities that
contribute to the tangles
characteristic of advanced
Alzheimer's disease. This
work ties several concepts
together and demonstrates
that Alzheimer's disease is
quite possibly a Type 3
diabetes”, explains de la
Monte, the leader of the
research.
Article written by
Hector Milla editor of
http://www.mydiabetessupply.com,
a website about diabetes
testing supply, or you
may read their last
article: Information on
Diabetes Drugs Called
Glucovance
(Glucovan) at
http://www.mydiabetessupply.com/1/information-diabetes-drugs-called-glucovance.html
Thanks for using this
diabetes article in your
website or ezine keeping
a live
link.
Article Source:
http://EzineArticles.com/?expert=Hector_Milla